Advertisement
UK markets closed
  • NIKKEI 225

    39,103.22
    +486.12 (+1.26%)
     
  • HANG SENG

    18,868.71
    -326.89 (-1.70%)
     
  • CRUDE OIL

    76.90
    -0.67 (-0.86%)
     
  • GOLD FUTURES

    2,329.90
    -63.00 (-2.63%)
     
  • DOW

    39,065.26
    -605.78 (-1.53%)
     
  • Bitcoin GBP

    53,365.89
    -1,296.40 (-2.37%)
     
  • CMC Crypto 200

    1,457.55
    -45.11 (-3.00%)
     
  • NASDAQ Composite

    16,736.03
    -65.51 (-0.39%)
     
  • UK FTSE All Share

    4,543.84
    -16.71 (-0.37%)
     

Allogene Therapeutics: Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Monday reported a loss of $65 million in its first quarter.

The South San Francisco, California-based company said it had a loss of 38 cents per share.

The results matched Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was also for a loss of 38 cents per share.

The immuno-oncology company posted revenue of $22,000 in the period, which also matched Street forecasts.

In the final minutes of trading on Monday, the company's shares hit $2.89. A year ago, they were trading at $6.18.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO